The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Psychiatry related information on Psychopharmacology


High impact information on Psychopharmacology


Chemical compound and disease context of Psychopharmacology


Biological context of Psychopharmacology


Anatomical context of Psychopharmacology

  • Administration of haloperidol for 2 weeks causes an increase within the caudate nucleus of asymmetrical synapses associated with a discontinuous or perforated, postsynaptic density (PSD) [Meshul et al. (1992), Psychopharmacology, 106:45-52; Meshul et al. (1992), Neuropsychopharmacology, 7:285-293] [19].
  • More research is needed in the field of psychopharmacology to classify central nervous system-active P-gp substrates and to characterize the utility of modulating P-gp activity at the blood-brain barrier [20].

Associations of Psychopharmacology with chemical compounds


Gene context of Psychopharmacology


Analytical, diagnostic and therapeutic context of Psychopharmacology


  1. The use of lithium and management of women with bipolar disorder during pregnancy and lactation. Llewellyn, A., Stowe, Z.N., Strader, J.R. The Journal of clinical psychiatry. (1998) [Pubmed]
  2. Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs. Molewijk, H.E., van der Poel, A.M., Mos, J., van der Heyden, J.A., Olivier, B. Psychopharmacology (Berl.) (1995) [Pubmed]
  3. Psychopharmacology of attention deficit disorder: pharmacokinetic, neuroendocrine, and behavioral measures following acute and chronic treatment with methylphenidate. Shaywitz, S.E., Hunt, R.D., Jatlow, P., Cohen, D.J., Young, J.G., Pierce, R.N., Anderson, G.M., Shaywitz, B.A. Pediatrics (1982) [Pubmed]
  4. Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea pigs. Brent, P.J. Neuropharmacology (1993) [Pubmed]
  5. Evidence-based psychopharmacology 1. Appraising a single therapeutic trial: what is the evidence for treating early Alzheimer's disease with donepezil? Warner, J.P. J. Psychopharmacol. (Oxford) (1999) [Pubmed]
  6. Sex and psychopharmacology: is natural estrogen a psychotropic drug in women? Stahl, S.M. Arch. Gen. Psychiatry (2001) [Pubmed]
  7. How reserpine and chlorpromazine act: the impact of key discoveries on the history of psychopharmacology. Curzon, G. Trends Pharmacol. Sci. (1990) [Pubmed]
  8. Clinical psychopharmacology may benefit from new advances in 5-HT pharmacology. Cooper, S.J., Abbott, A. Trends Pharmacol. Sci. (1988) [Pubmed]
  9. Clinical pharmacology of phenelzine. Robinson, D.S., Nies, A., Ravaris, C.L., Ives, J.O., Bartlett, D. Arch. Gen. Psychiatry (1978) [Pubmed]
  10. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. McDougle, C.J., Scahill, L., Aman, M.G., McCracken, J.T., Tierney, E., Davies, M., Arnold, L.E., Posey, D.J., Martin, A., Ghuman, J.K., Shah, B., Chuang, S.Z., Swiezy, N.B., Gonzalez, N.M., Hollway, J., Koenig, K., McGough, J.J., Ritz, L., Vitiello, B. The American journal of psychiatry. (2005) [Pubmed]
  11. Benzodiazepine site pharmacokinetic/pharmacodynamic quantification in man: direct measurement of drug occupancy and effects on the human brain in vivo. Malizia, A.L., Gunn, R.N., Wilson, S.J., Waters, S.H., Bloomfield, P.M., Cunningham, V.J., Nutt, D.J. Neuropharmacology (1996) [Pubmed]
  12. Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future research. Dursun, S.M., Kutcher, S. Med. Hypotheses (1999) [Pubmed]
  13. A role for dopamine in the psychopharmacology of electrical self-stimulation. Cooper, B.R., Breese, G.R. National Institute on Drug Abuse research monograph series. (1975) [Pubmed]
  14. Human cytochromes and some newer antidepressants: kinetics, metabolism, and drug interactions. Greenblatt, D.J., von Moltke, L.L., Harmatz, J.S., Shader, R.I. Journal of clinical psychopharmacology. (1999) [Pubmed]
  15. Nicotine psychopharmacology research: advancing science, public health, and global policy. Henningfield, J.E., Stolerman, I.P., Miczek, K.A. Psychopharmacology (Berl.) (2006) [Pubmed]
  16. Event-related potentials and psychopharmacology. Cholinergic modulation of P300. Dierks, T., Frölich, L., Ihl, R., Maurer, K. Pharmacopsychiatry (1994) [Pubmed]
  17. Recent developments in neurobiology: Part II. Neurotransmitter receptors and psychopharmacology. Hyman, S.E. Psychosomatics. (1988) [Pubmed]
  18. Differential psychopharmacology of methylphenidate and the neuropsychology of childhood hyperactivity. Hicks, R.E., Mayo, J.P., Clayton, C.J. Int. J. Neurosci. (1989) [Pubmed]
  19. Haloperidol-induced morphological alterations are associated with changes in calcium/calmodulin kinase II activity and glutamate immunoreactivity. Meshul, C.K., Tan, S.E. Synapse (1994) [Pubmed]
  20. Emerging significance of P-glycoprotein in understanding drug disposition and drug interactions in psychopharmacology. Carson, S.W., Ousmanou, A.D., Hoyler, S.L. Psychopharmacology bulletin. (2002) [Pubmed]
  21. Nicotine psychopharmacology: addiction, cognition and neuroadaptation. Stolerman, I.P., Mirza, N.R., Shoaib, M. Medicinal research reviews. (1995) [Pubmed]
  22. The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice. Stahl, S.M., Shayegan, D.K. The Journal of clinical psychiatry. (2003) [Pubmed]
  23. Psychopharmacology of bupropion in normal volunteers. Peck, A.W., Hamilton, M. The Journal of clinical psychiatry. (1983) [Pubmed]
  24. Substance P and the neurokinins: novel peptide neurotransmitters in psychopharmacology. Stahl, S.M. The Journal of clinical psychiatry. (1999) [Pubmed]
  25. The role of pharmacologic treatment guidelines for bipolar disorder. Perlis, R.H. The Journal of clinical psychiatry. (2005) [Pubmed]
  26. The emerging role of cytochrome P450 3A in psychopharmacology. Ketter, T.A., Flockhart, D.A., Post, R.M., Denicoff, K., Pazzaglia, P.J., Marangell, L.B., George, M.S., Callahan, A.M. Journal of clinical psychopharmacology. (1995) [Pubmed]
  27. Lack of imprinting of the human dopamine D4 receptor (DRD4) gene. Cichon, S., Nöthen, M.M., Wolf, H.K., Propping, P. Am. J. Med. Genet. (1996) [Pubmed]
  28. The psychopharmacology of tachykinin NK-3 receptors in laboratory animals. Massi, M., Panocka, I., de Caro, G. Peptides (2000) [Pubmed]
  29. Psychopharmacology of ADHD: children and adolescents. Findling, R.L., Dogin, J.W. The Journal of clinical psychiatry. (1998) [Pubmed]
  30. DNA variation and psychopharmacology of the human serotonin receptor 1B (HTR1B) gene. Sanders, A.R., Duan, J., Gejman, P.V. Pharmacogenomics (2002) [Pubmed]
  31. Serotonin: neurotransmitter "a la mode". Report on the Third International I.T.E.M.-LABO symposium on strategies in psychopharmacology: serotonin: animal models and clinical targets. Porsolt, R.D. Pharmacopsychiatry (1993) [Pubmed]
  32. Government initiatives in autism clinical trials. Vitiello, B., Wagner, A. CNS spectrums. (2004) [Pubmed]
WikiGenes - Universities